Filing Details

Accession Number:
0000899243-18-014563
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-31 17:13:47
Reporting Period:
2018-05-29
Accepted Time:
2018-05-31 17:13:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1461993 Melinta Therapeutics Inc. W MLNT Pharmaceutical Preparations (2834) 454440364
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1582285 Mark Daniel Wechsler C/O Melinta Therapeutics, Inc.
300 George Street, Suite 301
New Haven CT 06511
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-29 50,000 $5.00 50,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. These shares were purchased from the underwriters pursuant to an underwritten public offering by the Issuer. The offering closed on May 29, 2018.